Edwards Lifesciences EW

HealthcareMarket cap $45B2 connections

Edwards Lifesciences makes transcatheter heart valves that replace diseased aortic valves without open-heart surgery. Its TAVR technology has transformed cardiac care - now used in 100,000+ procedures annually. Edwards also makes advanced hemodynamic monitoring systems used in ICUs globally.

Explore Edwards Lifesciences on the interactive map Relationship timeline Find a path to another company

Partners 1

Strategic partnerships, joint products and alliances

MedtronicHealthcare · $100BCompeting transcatheter heart valve platforms

Competitors 2

Companies it competes with

Boston ScientificHealthcare · $114BTranscatheter valve competition
MedtronicHealthcare · $100BCardiac valve rivalry

Other Healthcare companies

Eli Lilly UnitedHealth Novo Nordisk Johnson & Johnson AbbVie Merck AstraZeneca Thermo Fisher Novartis Abbott Labs

Embed this on your site

Show Edwards Lifesciences's network in an article or report - it updates as our data does.

<iframe src="https://vexmap.com/embed.html?co=EW" width="600" height="420" style="border:0;border-radius:12px;max-width:100%" title="Edwards Lifesciences on VexMap" loading="lazy"></iframe>

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.